Evidence map›Paper›PMID 27283835›Full record

ArticleBreast cancer research and treatment2016

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.

Tulay Koru-Sengul, Ana M Santander, Feng Miao, Lidia G Sanchez, Merce Jorda, Stefan Glück, Tan A Ince, Mehrad Nadji, Zhibin Chen, Manuel L Penichet and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Breast cancer research and treatment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 2 syntheses or guidelines pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Hofbauer Cells in Pregnancies Complicated by Gestational Diabetes Mellitus and Pathological Fetal Growth.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Single-nuclei sequencing of uterine serous carcinoma reveals racial differences in immune signaling.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Article
  18. CD163Breast cancer research : BCR · 2024
    Article
  19. The role of tumor-associated macrophages in tumor immune evasion.Journal of cancer research and clinical oncology · 2024
    Review
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Tulay Koru-SengulDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Ana M SantanderDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, 1600 NW 10th Avenue Rosenstiel Medical School Building Suite 3123A, P.O. Box 016960 (R-138), Miami, FL, 33101, USA.
Feng MiaoSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Lidia G SanchezDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, 1600 NW 10th Avenue Rosenstiel Medical School Building Suite 3123A, P.O. Box 016960 (R-138), Miami, FL, 33101, USA.
Merce JordaDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA.
Stefan GlückDepartment of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Tan A InceDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA.
Mehrad NadjiDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA.
Zhibin ChenDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, 1600 NW 10th Avenue Rosenstiel Medical School Building Suite 3123A, P.O. Box 016960 (R-138), Miami, FL, 33101, USA.
Manuel L PenichetDivision of Surgical Oncology, Department of Surgery, UCLA, Los Angeles, CA, USA.
Margot P ClearyHormel Institute, University of Minnesota, Austin, MN, 55912, USA.
Marta Torroella-KouriDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. mtorroella@med.miami.edu.ORCID http://orcid.org/0000-0003-3943-6656
University of Miami · USUniversity of California, Los Angeles · USUniversity of Minnesota · US

Funding

A Novel Anti-HER2/neu IgE for Breast Cancer TherapyR01CA181115 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PENICHET, MANUEL L · 2014 to 2018
$2.5M
Prevention of mammary tumors by metformin in comparison to calorie restrictionR01CA157012 · NCI · UNIVERSITY OF MINNESOTA · PI CLEARY, MARGOT P · 2011 to 2015
$1.6M
Role of obesity and breast fat tissue inflammation in breast cancer promotion.R21CA176055 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI TORROELLA-KOURI, MARTA · 2013 to 2014
$419k
Role of Th1/17 in gastric tumor initiation triggered by CTLA4 dysregulationR21CA178675 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CHEN, ZHIBIN · 2013 to 2014
$360k
Computational and Biological Deconvolution of Epigenomic DatasetsR01ES024991 · NIEHS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI INCE, TAN A. · 2014 to 2014
$323k
NCI NIH HHS R01 CA157012NCI NIH HHS R01 CA181115NCI NIH HHS R21 CA176055NCI NIH HHS R21 CA178675NIEHS NIH HHS R01 ES024991
6 · The paper itself

Abstract

Racial disparities in breast cancer incidence and outcome are a major health care challenge. Patients in the black race group more likely present with an early onset and more aggressive disease. The occurrence of high numbers of macrophages is associated with tumor progression and poor prognosis in solid malignancies. Macrophages are observed in adipose tissues surrounding dead adipocytes in "crown-like structures" (CLS). Here we investigated whether the numbers of CD163+ tumor-associated macrophages (TAMs) and/or CD163+ CLS are associated with patient survival and whether there are significant differences across blacks, non-black Latinas, and Caucasians. Our findings confirm that race is statistically significantly associated with the numbers of TAMs and CLS in breast cancer, and demonstrate that the highest numbers of CD163+ TAM/CLS are found in black breast cancer patients. Our results reveal that the density of CD206 (M2) macrophages is a significant predictor of progression-free survival univariately and is also significant after adjusting for race and for HER2, respectively. We examined whether the high numbers of TAMs detected in tumors from black women were associated with macrophage proliferation, using the Ki-67 nuclear proliferation marker. Our results reveal that TAMs actively divide when in contact with tumor cells. There is a higher ratio of proliferating macrophages in tumors from black patients. These findings suggest that interventions based on targeting TAMs may not only benefit breast cancer patients in general but also serve as an approach to remedy racial disparity resulting in better prognosis patients from minority racial groups.

Indexed as

Antigens, CDAntigens, Differentiation, MyelomonocyticBlack or African AmericanBreast NeoplasmsCD163 AntigenCell ProliferationDisease-Free SurvivalFemaleHispanic or LatinoHumansLectins, C-TypeMacrophagesMannose-Binding LectinsMannose ReceptorPrognosisReceptors, Cell SurfaceAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenLectins, C-TypeMannose-Binding LectinsMannose ReceptorReceptors, Cell SurfaceBreast cancerCrown-like structuresInflammationMacrophagesRace/ethnicities

Identifiers

PMID27283835
PMCPMC5129629
OpenAlexW2414790256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.